• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中亚同行评议员:基于 Publons 的分析。

Peer Reviewers in Central Asia: Publons Based Analysis.

机构信息

Kalinga Institute of Medical Sciences, KIIT University, Bhubaneswar, India.

Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.

出版信息

J Korean Med Sci. 2021 Jun 28;36(25):e169. doi: 10.3346/jkms.2021.36.e169.

DOI:10.3346/jkms.2021.36.e169
PMID:34184435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8239425/
Abstract

BACKGROUND

The five Central Asian republics comprise of Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, and Uzbekistan. Their research and publication activities are gradually improving but there is limited data on how good their peer reviewing practices are.

METHODS

We have use the Publons database to extract information on the reviewers registered including the number of verified review, Publons award winners, and top universities in the domain of peer reviewing. This has been analysed overall and country wise.

RESULTS

Of 15,764 researchers registered on Publons, only 370 (11.7%) have verified records of peer-reviewing. There are 8 Publons award winners. There is great heterogeneity in the number of active reviewers across the five countries. Kazakhstan and Uzbekistan account for more than 90% of verified reviewers. Only Kazakhstan has more than 100 active reviewers and 6 Publons award recipients. Amongst the top 20 reviewers from Central Asia, half of them are from the Nazarbayev University, Nur-Sultan, Kazakhstan. Three countries have less than 10 universities registered on Publons.

CONCLUSION

Central Asia has a good number of peer reviewers on Publons though only a minority of researchers are involved in peer reviewing. However, the heterogeneity between the nations can be best dealt with by promoting awareness and international networking including e-learning and mentoring programs.

摘要

背景

中亚五国包括哈萨克斯坦、吉尔吉斯斯坦、塔吉克斯坦、土库曼斯坦和乌兹别克斯坦。它们的研究和出版活动在逐步改善,但关于同行评审实践水平的数据有限。

方法

我们使用 Publons 数据库提取注册评审员的信息,包括已核实的评审数量、Publons 获奖者以及同行评审领域的顶尖大学。对整体和各国进行了分析。

结果

在 Publons 上注册的 15764 名研究人员中,只有 370 人(11.7%)有经过验证的同行评审记录。有 8 位 Publons 获奖者。五个国家的活跃评审员数量存在很大差异。哈萨克斯坦和乌兹别克斯坦占已核实评审员的 90%以上。只有哈萨克斯坦有超过 100 名活跃的评审员和 6 位 Publons 获奖者。在中亚排名前 20 的评审员中,有一半来自哈萨克斯坦努尔苏丹的纳扎尔巴耶夫大学。有三个国家在 Publons 上注册的大学少于 10 所。

结论

尽管只有少数研究人员参与同行评审,但中亚地区 Publons 上的同行评审员数量较多。然而,各国之间的差异可以通过提高认识和国际网络联系来解决,包括电子学习和指导计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/34933a5e8bb1/jkms-36-e169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/8b229b6eac23/jkms-36-e169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/b1f5c2a86091/jkms-36-e169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/34933a5e8bb1/jkms-36-e169-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/8b229b6eac23/jkms-36-e169-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/b1f5c2a86091/jkms-36-e169-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f3b/8239425/34933a5e8bb1/jkms-36-e169-g003.jpg

相似文献

1
Peer Reviewers in Central Asia: Publons Based Analysis.中亚同行评议员:基于 Publons 的分析。
J Korean Med Sci. 2021 Jun 28;36(25):e169. doi: 10.3346/jkms.2021.36.e169.
2
Top Central Asian Educational Institutions on Publons: Analysis of Researchers and Reviewers.Publons 上中亚顶尖教育机构:研究人员和审稿人的分析。
J Korean Med Sci. 2021 May 31;36(21):e144. doi: 10.3346/jkms.2021.36.e144.
3
Characteristics of scholars who review for predatory and legitimate journals: linkage study of Cabells Scholarly Analytics and Publons data.掠夺性期刊和合法期刊审稿人特征的比较:Cabells Scholarly Analytics 和 Publons 数据的关联研究。
BMJ Open. 2021 Jul 21;11(7):e050270. doi: 10.1136/bmjopen-2021-050270.
4
Post-Soviet Central Asia: a summary of the drug situation.后苏联时代的中亚:毒品形势综述
Int J Drug Policy. 2014 Nov;25(6):1186-94. doi: 10.1016/j.drugpo.2014.05.004. Epub 2014 May 21.
5
Characteristics of 'mega' peer-reviewers.“超级”同行评审者的特征。
Res Integr Peer Rev. 2022 Feb 21;7(1):1. doi: 10.1186/s41073-022-00121-1.
6
[Former Soviet Central Asia: a cultural and demographic entity].[前苏联中亚地区:一个文化与人口实体]
Cah Mediterr Orient Monde Turco Iran. 1993(16):335-49.
7
Biosurveillance in Central Asia: Successes and Challenges of Tick-Borne Disease Research in Kazakhstan and Kyrgyzstan.中亚的生物监测:哈萨克斯坦和吉尔吉斯斯坦蜱传疾病研究的成功与挑战。
Front Public Health. 2016 Feb 1;4:4. doi: 10.3389/fpubh.2016.00004. eCollection 2016.
8
Publication Productivity in Central Asia and Countries of the Former Soviet Union.中亚及前苏联国家的出版物产出情况
Cent Asian J Glob Health. 2016 Dec 13;5(1):261. doi: 10.5195/cajgh.2016.261. eCollection 2016.
9
Cervical cancer screening and prevention in Kazakhstan and Central Asia.哈萨克斯坦及中亚地区的宫颈癌筛查与预防
J Med Screen. 2021 Mar;28(1):48-50. doi: 10.1177/0969141320902482. Epub 2020 Jan 24.
10
[Results and prospects of the development of traumatologic-orthopedic services in the republics of Central Asia and Kazakhstan].[中亚各共和国及哈萨克斯坦创伤骨科服务发展的成果与前景]
Ortop Travmatol Protez. 1988 Nov(11):1-5.

引用本文的文献

1
Prejudice, Interests, Jealousy: Inappropriate Peer Reviewers May Be Exacerbating Inequality in Academic Publication in Health Research.偏见、利益、嫉妒:不恰当的同行评审可能加剧健康研究学术发表中的不平等现象。
J Korean Med Sci. 2023 Aug 21;38(33):e256. doi: 10.3346/jkms.2023.38.e256.
2
Comparative Analysis of Central Asian Publication Activity Using SCImago Journal & Country Rank Data in 1996-2021.1996-2021 年基于 SCImago 期刊和国家排名数据的中亚出版活动比较分析。
J Korean Med Sci. 2023 Apr 10;38(14):e104. doi: 10.3346/jkms.2023.38.e104.

本文引用的文献

1
Top Central Asian Educational Institutions on Publons: Analysis of Researchers and Reviewers.Publons 上中亚顶尖教育机构:研究人员和审稿人的分析。
J Korean Med Sci. 2021 May 31;36(21):e144. doi: 10.3346/jkms.2021.36.e144.
2
How do Clarivate Analytics and Publons propose to fortify peer review in the COVID-19 era?科睿唯安(Clarivate Analytics)和Publons计划如何在新冠疫情时代加强同行评审?
J Taibah Univ Med Sci. 2021 Feb 13;16(2):139-143. doi: 10.1016/j.jtumed.2021.01.008. eCollection 2021 Apr.
3
Present-day tools for assessing publishing integrity in biomedical science represent valuable work in progress.
当前用于评估生物医学科学出版诚信的工具是正在进行的有价值的工作。
Clin Rheumatol. 2021 May;40(5):2111-2112. doi: 10.1007/s10067-021-05702-x. Epub 2021 Mar 25.
4
Peer review guidance: a primer for researchers.同行评审指南:研究人员入门指南
Reumatologia. 2021;59(1):3-8. doi: 10.5114/reum.2021.102709. Epub 2021 Feb 28.
5
Social Media for Scholarly Communication in Central Asia and Its Neighbouring Countries.中亚及中亚邻国的学术传播社交媒体
J Korean Med Sci. 2021 Jan 25;36(4):e36. doi: 10.3346/jkms.2021.36.e36.
6
Building trust in journals and in peer review: need of the hour during the COVID-19 pandemic.建立对期刊和同行评审的信任:新冠疫情期间的当务之急。
Rheumatol Int. 2021 Feb;41(2):501-502. doi: 10.1007/s00296-020-04741-y. Epub 2020 Nov 7.
7
COVID-19: a stress test for trust in science.新冠疫情:对科学信任的压力测试。
Lancet. 2020 Sep 19;396(10254):799. doi: 10.1016/S0140-6736(20)31954-1.
8
Moving towards online rheumatology education in the era of COVID-19.迈向 COVID-19 时代的在线风湿病学教育。
Clin Rheumatol. 2020 Nov;39(11):3215-3222. doi: 10.1007/s10067-020-05405-9. Epub 2020 Sep 17.
9
Integrity of clinical research conduct, reporting, publishing, and post-publication promotion in rheumatology.风湿病学中临床研究行为、报告、出版和出版后推广的完整性。
Clin Rheumatol. 2020 Apr;39(4):1049-1060. doi: 10.1007/s10067-020-04965-0. Epub 2020 Feb 5.
10
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning.绘制中东欧、俄罗斯联邦和中亚地区的癌症研究图谱:对未来国家癌症控制规划的影响。
Eur J Cancer. 2018 Nov;104:127-136. doi: 10.1016/j.ejca.2018.08.024. Epub 2018 Oct 20.